• 2020
  • 2019
  • 2018
  • 2017
  • 2016

Timothy J. Peter

Faruqi & Faruqi Defeats Motion to Dismiss In Godiva Consumer Class Action

Posted by Timothy J. Peter on 05/29/2020

On May 29, 2020, Judge Alison J. Nathan of the Southern District of New York issued a ruling granting in part and denying in part Godiva's motion to dismiss plaintiff's complaint. The class action challenges Godiva's use of the "Belgium 1926" representation on the label, when certain chocolates produced by Godiva are made in the USA. The Court ...

Read more

Stephen Doherty

Farmers Claim Price Fixing Is No Small Peanuts

Posted by Stephen Doherty on 05/29/2020

According to a Complaint filed by a group of peanut farmers, the two leading peanut shelling companies conspired to fix prices of raw and harvested peanuts by underreporting their inventory to the U.S. Department of Agriculture in order to make the market appear to be oversupplied. The plaintiffs claim that Birdsong Corp. and Golden Peanut ...

Read more

Adam Steinfeld

Relief for New York City’s Restaurants Offers Little Comfort for the Future

Posted by Adam Steinfeld on 05/27/2020

On March 22, New York State's PAUSE order went into effect, shuttering non-essential businesses statewide, cancelling "non-essential gatherings," and urging individuals to limit travel and recreational activities. This order will remain in effect until at least May 28 (and likely extend further) for regions that have not yet met the initial ...

Read more

Raymond N. Barto

Mylan and Pfizer’s Class Certification Appeal in EpiPen Action Fails

Posted by Raymond N. Barto on 05/27/2020

The Tenth Circuit rejected Pfizer and Mylan's request to seek an immediate reversal of United States District Court Judge Daniel D. Crabtree's order certifying two classes of consumers and third-party payors in the EpiPen multidistrict litigation centralized in the District of Kansas. Finding that the district court had conducted a rigorous ...

Read more

Robert W. Killorin

Federal Courts and SEC Lean on Technology to Carry On in Face of Covid-19 Crisis

Posted by Robert W. Killorin on 05/27/2020

Following suit with many businesses in America, the SEC has announced that a sponsored conference will not be cancelled, but instead will be rescheduled as a virtual and interactive conference that is open to the public. The conference, titled "Spotlight on Transparency: A Discussion of Secondary Market Municipal Securities Disclosure Practices," ...

Read more

Joshua Nassir

Zoom’s Lack of Security Leads to Consumer and Shareholder Class Actions

Posted by Joshua Nassir on 05/27/2020

COVID-19 has restructured the way people conduct their daily activities, and perhaps most notably, the way people communicate with each other. Zoom Communications Inc. ("Zoom"), a communications company offering video-telephonic services, has been at the forefront of providing a means for society to stay connected during these hard times. ...

Read more

David Calvello

Indicted Generic Drug Price-Fixer Wants to Move Criminal Case to the Southern District of New York

Posted by David Calvello on 05/27/2020

Ara Aprahamian, a former executive of Taro Pharmaceuticals who is accused of engaging in a conspiracy to fix prices for generic prescription drugs, recently petitioned to move his criminal case from the Eastern District of Pennsylvania to the Southern District of New York. See Mot. to Transfer, U.S. v. Aprahamian, 20-cr-00064-RBS (E.D. Pa.), ...

Read more

Sherief Morsy

SEC Takes Action Against Company For False And Misleading COVID-19 Statements

Posted by Sherief Morsy on 05/27/2020

On May 14, 2020, the United States Securities and Exchange Commission ("SEC") announced it was charging Turbo Global Partners, Inc. ("Turbo") and its chief executive officer, Robert W. Singerman ("Singerman") with fraud based on statements made in its press releases and suspended trading in Turbo. See SEC Litigation Release No. 24820, SEC ...

Read more

David Felderman


Posted by David Felderman on 05/27/2020

A class action lawsuit was filed in Massachusetts federal court last week against Harvard University. The suit, brought on behalf of a proposed class of students, alleges that the university improperly retained tuition funds for services it is no longer providing as a result of the Covid-19 pandemic. Specifically, the complaint alleges that ...

Read more

Maxwell Michael

Democratic Lawmakers Renew Calls For A Merger Ban During the COVID-19 Pandemic

Posted by Maxwell Michael on 05/26/2020

On May 13, 2020, Senators Elizabeth Warren (D-MA) and Amy Klobuchar (D-MN) and Representative David Cicilline (D-RI) signed a letter to the Federal Reserve and the Treasury Department asking the Fed and the Treasury to restrict large corporations that received coronavirus pandemic funds from engaging in mergers. The letter did not contain ...

Read more

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania